Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence.
Grainger
David J
DJ
Translational Research Unit, Papworth Hospital NHS Foundation Trust, Papworth-Everard, Cambridge, United Kingdom. djg15@cam.ac.uk
Schofield
Peter M
PM
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control; D004195:Disease Models, Animal; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D013629:Tamoxifen / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D004965:Estrogen Antagonists; D013629:Tamoxifen